PROVENTION BIO INC (PRVB) Stock Analyst Ratings
USA - NASDAQ:PRVB - US74374N1028 - Common Stock
24.98 USD
+0.75 (+3.1%)
25 USD
+0.02 (+0.08%)
ChartMill assigns a Buy % Consensus number of 78% to PRVB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is -2% below the current price.
PRVB was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about PRVB.
In the last month the buy percentage fell by 8 points. So the trust of analysts is decreasing.
PRVB was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-03-14 | SMBC Nikko | Downgrade | Outperform -> Neutral |
| 2023-03-14 | Jefferies | Downgrade | Buy -> Hold |
| 2023-03-13 | Chardan Capital | Maintains | Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-21 | Chardan Capital | Maintains | Buy |
| 2022-11-21 | SVB Leerink | Maintains | Outperform |
| 2022-11-18 | Oppenheimer | Maintains | Outperform |
| 2022-11-18 | Jefferies | Maintains | Buy |
| 2022-11-04 | Chardan Capital | Maintains | Buy |
| 2022-10-07 | Jefferies | Maintains | Buy |
| 2022-09-20 | Jefferies | Initiate | Buy |
| 2022-08-05 | Chardan Capital | Maintains | Buy |
| 2022-07-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-06 | Oppenheimer | Maintains | Outperform |
| 2021-08-06 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-13 | Chardan Capital | Maintains | Buy |
| 2021-04-12 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-04-09 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-04-09 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2021-04-09 | SVB Leerink | Maintains | Outperform |
| 2021-02-22 | HC Wainwright & Co. | Maintains | Buy |
PROVENTION BIO INC / PRVB FAQ
What is the price target for PRVB stock?
12 analysts have analysed PRVB and the average price target is 24.48 USD. This implies a price decrease of -2% is expected in the next year compared to the current price of 24.98.
Can you provide the consensus rating for PROVENTION BIO INC stock?
The consensus rating for PROVENTION BIO INC (PRVB) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.